Urinary monitor dev Potrero Medical closes $27m Series C

Predictive health company Potrero Medical said yesterday it closed a $26.6 million Series C funding to help support commercialization of its flagship Accuryn monitoring system. The San Francisco-based company’s Accuryn system is designed to use urinary catheters as diagnostic tools. The device provides real-time measurements of intra-abdominal pressure, urine output and core body temperature and can be integrated into hospital EMR systems, the company said. Financing in the round was led by GT Healthcare Capital Partners and Sonder Capital, Potrero Medical said. “We are excited to be a part of Potrero Medical’s vision, which has the potential to extend beyond the intensive care unit into areas such as the cardiac catheterization lab and operating room,” GT Healthcare managing partner & founder Alan Au said in a press release. Potrero said that funds will be used to help support continued commercialization of the Accuryn monitor and for the development of an artificial intelligence platform intended to aid in the identification of life-threatening events, such as acute kidney injury. “As robotics advanced medicine by improving minimally invasive surgery, predictive health is revolutionizing the way physicians monitor and treat their patients. Potrero Medical is leading the way with the Accuryn  monitoring system. Using artificial intelligence and data analytics, the Accuryn system will be a transformative advancement in predictive health,”...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Diagnostics Urology Potrero Medical Source Type: news